DEFA14A: Pliant Therapeutics Sets Date for 2025 Annual Meeting, Outlines Key Proposals
Proxy Statement
Pliant Therapeutics announces its 2025 Annual Meeting of Stockholders to be held virtually on June 5, 2025, with voting open until June 4, 2025.
Summary
- Pliant Therapeutics has scheduled its Annual Meeting of Stockholders for June 5, 2025.
- The meeting will be held virtually at 8:30 a.m. Pacific Time.
- Stockholders can vote on several proposals, including the election of three Class II directors, an advisory vote on executive compensation, an amendment to the company's certificate of incorporation, and the ratification of Deloitte & Touche LLP as the independent accounting firm.
- The deadline to request a paper or email copy of the proxy materials is May 22, 2025.
- Voting is open until June 4, 2025, at 11:59 PM ET.
Sentiment
Score: 7
Explanation: The document is a routine announcement of an annual meeting, with standard proposals. The sentiment is neutral to slightly positive as it reflects normal corporate governance.
Positives
- The company is providing multiple avenues for stockholders to access proxy materials and vote, including online, phone, and email.
- The proposals include measures to limit officer liability, which could attract and retain qualified individuals.
Future Outlook
The document outlines the agenda for the upcoming annual meeting and seeks stockholder approval on key governance matters.
Industry Context
This announcement is a standard corporate procedure for publicly traded companies, ensuring shareholders have the opportunity to participate in key decisions.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to Certificate of Incorporation | To limit the liability of certain officers of Pliant Therapeutics, Inc. as permitted by Delaware law. | Upon approval | Aims to attract and retain qualified officers by reducing their personal liability. |
Stakeholder Impact
- Shareholders have the opportunity to vote on key company matters.
- Employees may be indirectly affected by the decisions made at the meeting, particularly regarding executive compensation and officer liability.
Next Steps
- Stockholders should review the proxy materials and vote on the proposals.
- The company will hold the Annual Meeting on June 5, 2025.
Key Dates
| Date | Description |
|---|---|
| May 22, 2025 | Deadline to request a paper or email copy of the proxy materials. |
| June 4, 2025 | Voting deadline at 11:59 PM ET. |
| June 5, 2025 | Annual Meeting of Stockholders at 8:30 a.m. Pacific Time. |
| December 31, 2025 | Fiscal year end for which Deloitte & Touche LLP is being ratified as the independent accounting firm. |
Keywords
Annual Meeting, Proxy Statement, Stockholders, Voting, Directors, Executive Compensation, Deloitte & Touche, Pliant Therapeutics
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.